Add new attachment

Only authorized users are allowed to upload new attachments.

This page (revision-10) was last changed on 24-Dec-2012 10:38 by 1614216108

This page was created on 11-Apr-2012 12:37 by UnknownAuthor

Only authorized users are allowed to rename pages.

Only authorized users are allowed to delete pages.

Difference between version and

At line 5 added 2 lines
__项目介绍 :__\\
  包括纤溶酶原S活性(PLG:A)检测和抗原含量(PLG:Ag)检测。纤溶酶原被激活后变成纤溶酶,可以降解纤维蛋白原、纤维蛋白和多种凝血因子,起着对抗凝血和溶栓的生理作用。血浆纤溶酶原的测定有助于判断纤溶系统活性。\\
At line 7 changed 2 lines
  1.病理性增高:表明纤溶酶原激活受阻,纤溶系统活性减弱。常见于血栓前状态和血栓性疾病,如心肌梗死、心绞痛、脑血管病变、糖尿病、妊娠高血压症、深静脉血栓形成、肾病综合征等。\\
  2.病理性降低:表明纤溶酶原激活过度,纤溶系统活性增强,如先天性PLG缺乏症、纤溶亢进症、DIC等。\\
1.病理性增高:\\表明纤溶酶原激活受阻,纤溶系统活性减弱。常见于血栓前状态和血栓性疾病,如心肌梗死、心绞痛、脑血管病变、糖尿病、妊娠高血压症、深静脉血栓形成、肾病综合征等。\\
2.病理性降低:\\表明纤溶酶原激活过度,纤溶系统活性增强,如先天性PLG缺乏症、纤溶亢进症、DIC等。\\
At line 13 added one line
血浆 PLG:A(85.55±27.83)%,血浆PLG:Ag(0.22±0.03)g/L。
At line 16 added one line
无。
At line 19 added one line
无。
At line 16 changed 4 lines
%%tab-影响因素
一、项目介绍\\
  包括纤溶酶原S活性(PLG:A)检测和抗原含量(PLG:Ag)检测。纤溶酶原被激活后变成纤溶酶,可以降解纤维蛋白原、纤维蛋白和多种凝血因子,起着对抗凝血和溶栓的生理作用。血浆纤溶酶原的测定有助于判断纤溶系统活性。\\
  二、方法学评价\\
%%tab-方法学评价
At line 21 removed 3 lines
  病人准备:无特殊要求。\\
  标本采集和运送要求:\\
  空腹肝素抗凝全血标本。\\
At line 24 added 2 lines
%%tab-病人准备
无特殊要求。\\
At line 27 added 4 lines
%%tab-标本采集和运送要求
空腹肝素抗凝全血标本。\\
/%
/%
Version Date Modified Size Author Changes ... Change note
10 24-Dec-2012 10:38 0.908 kB 1614216108 to previous
9 19-Dec-2012 11:33 0.855 kB 1614216108 to previous | to last
8 14-Dec-2012 14:37 0.88 kB 1614216108 to previous | to last
7 12-Jul-2012 15:37 0.678 kB 1614216108 to previous | to last
6 12-Jul-2012 15:37 0.681 kB 1614216108 to previous | to last
5 03-May-2012 13:33 0.704 kB 1614216108 to previous | to last
4 25-Apr-2012 15:33 0.696 kB 1614216108 to previous | to last
3 24-Apr-2012 10:48 0.671 kB 1614216108 to previous | to last
2 13-Apr-2012 16:19 0.663 kB 1614216108 to previous | to last
1 11-Apr-2012 12:37 0.606 kB UnknownAuthor to last
« This page (revision-10) was last changed on 24-Dec-2012 10:38 by 1614216108